Discovery of novel SSRIs for a combination-treatment with pimavanserin
{{output}}
A growing body of evidence indicates that inadequate symptom-relief from medical treatment with SSRIs may be enhanced by concomitant blockade of 5-HT2A. In a discovery program directed towards finding novel SSRIs suitable for combining with the 5-HT2A inverse ... ...
